General & Plastic Surgery Devices - France

France is expected to experience significant growth in the General & Plastic Surgery Devices market market.
By 2024, the projected revenue for this market in France is estimated to reach US$1.01bn.
This growth is expected to continue with an annual growth rate of 3.49% from 2024 to 2029.
By 2029, the market volume is projected to reach US$1.19bn in France.
In comparison to other countries, the United States is predicted to generate the most revenue in the General & Plastic Surgery Devices market market.
In 2024 alone, the projected revenue for the United States is estimated to be US$9.84bn.
France continues to be a leading innovator in the General & Plastic Surgery Devices market, with cutting-edge technologies and a strong emphasis on patient safety and satisfaction.

Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.

Disposable surgical supplies
Open surgery instruments
Minimally invasive surgery instruments

Services (i.e., treatment expenses)
Blood and transplants derived from the human body
In vitro diagnostics
Diagnostic imaging

The General & Plastic Surgery Devices market in France has been experiencing steady growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in France have played a significant role in the growth of the General & Plastic Surgery Devices market. French consumers are increasingly seeking cosmetic procedures to enhance their appearance and improve their self-confidence. This trend has led to a higher demand for surgical and non-surgical devices used in general and plastic surgery. Trends in the market also contribute to the growth of the General & Plastic Surgery Devices market in France. Technological advancements have led to the development of innovative devices that provide more precise and effective results. For example, the introduction of minimally invasive procedures has gained popularity among French consumers due to their shorter recovery time and reduced scarring. Local special circumstances in France have also influenced the growth of the General & Plastic Surgery Devices market. The country has a well-established healthcare system that provides access to quality healthcare services, including general and plastic surgery. Additionally, France is known for its high standards in healthcare and has a large number of skilled surgeons and medical professionals specializing in these fields. Underlying macroeconomic factors have also played a role in the growth of the General & Plastic Surgery Devices market in France. The country has a stable economy with a high level of disposable income among its population. This allows consumers to invest in cosmetic procedures and the devices used in these procedures. Furthermore, France is a popular destination for medical tourism, attracting patients from around the world who seek high-quality healthcare services. In conclusion, the General & Plastic Surgery Devices market in France is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. French consumers' increasing interest in cosmetic procedures, technological advancements in the industry, France's well-established healthcare system, and the country's stable economy all contribute to the development of this market.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.